October 14, 2018
2 min watch
Save
VIDEO: Ocular Therapeutix updates product pipeline
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Vascular Medicine.
Added to email alerts
You've successfully added Vascular Medicine to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Vascular Medicine to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — From OSN New York 2018, Antony Mattessich, CEO of Ocular Therapeutix, discusses progress toward approval of the dexamethasone implant, Dextenza, as well as other products in the company’s pipeline.
Read more from OSN New York and OSN New York Retina
View allJanuary 12, 2025
9 min watch
Save
January 11, 2025
3 min watch
Save
January 08, 2025
7 min watch
Save
January 08, 2025
10 min watch
Save
January 07, 2025
8 min watch
Save
January 06, 2025
10 min watch
Save
January 06, 2025
9 min watch
Save
January 05, 2025
8 min watch
Save
January 04, 2025
8 min watch
Save
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Vascular Medicine.
Added to email alerts
You've successfully added Vascular Medicine to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Vascular Medicine to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.